254 related articles for article (PubMed ID: 27702939)
1. Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis.
Sitasuwan P; Melendez C; Marinova M; Mastrianni KR; Darragh A; Ryan E; Lee LA
J Anal Toxicol; 2016 Oct; 40(8):601-607. PubMed ID: 27702939
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.
French D; Wu A; Lynch K
Bioanalysis; 2011 Dec; 3(23):2603-12. PubMed ID: 22136049
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection.
Dahn T; Gunn J; Kriger S; Terrell AR
Methods Mol Biol; 2010; 603():411-22. PubMed ID: 20077093
[TBL] [Abstract][Full Text] [Related]
4. GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood.
Meatherall R
J Anal Toxicol; 2005; 29(5):301-8. PubMed ID: 16105253
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the usefulness of an oxycodone immunoassay in combination with a traditional opiate immunoassay for the screening of opiates in urine.
Gingras M; Laberge MH; Lefebvre M
J Anal Toxicol; 2010 Mar; 34(2):78-83. PubMed ID: 20223099
[TBL] [Abstract][Full Text] [Related]
6. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.
Smith ML; Hughes RO; Levine B; Dickerson S; Darwin WD; Cone EJ
J Anal Toxicol; 1995; 19(1):18-26. PubMed ID: 7536861
[TBL] [Abstract][Full Text] [Related]
7. LC-MS-MS Method for Analysis of Opiates in Wastewater During Football Games II.
Gul W; Stamper B; Godfrey M; Gul SW; ElSohly MA
J Anal Toxicol; 2016 Jun; 40(5):330-7. PubMed ID: 27052850
[TBL] [Abstract][Full Text] [Related]
8. GC-MS confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine.
Meatherall R
J Anal Toxicol; 1999; 23(3):177-86. PubMed ID: 10369327
[TBL] [Abstract][Full Text] [Related]
9. Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
Cone EJ; Zichterman A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH
Forensic Sci Int; 2010 May; 198(1-3):58-61. PubMed ID: 20036472
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS.
Grabenauer M; Bynum ND; Moore KN; White RM; Mitchell JM; Hayes ED; Flegel R
J Anal Toxicol; 2018 Mar; 42(2):115-125. PubMed ID: 29186453
[TBL] [Abstract][Full Text] [Related]
11. Development of a Quantitative LC-MS-MS Assay for Codeine, Morphine, 6-Acetylmorphine, Hydrocodone, Hydromorphone, Oxycodone and Oxymorphone in Neat Oral Fluid.
Grabenauer M; Moore KN; Bynum ND; White RM; Mitchell JM; Hayes ED; Flegel R
J Anal Toxicol; 2018 Jul; 42(6):392-399. PubMed ID: 29554298
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of opioids in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Goldberger BA; Chronister CW; Merves ML
Methods Mol Biol; 2010; 603():399-410. PubMed ID: 20077092
[TBL] [Abstract][Full Text] [Related]
13. Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry.
Nowatzke W; Zeng J; Saunders A; Bohrer A; Koenig J; Turk J
J Pharm Biomed Anal; 1999 Sep; 20(5):815-28. PubMed ID: 10701990
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous identification and quantitation of codeine, morphine, hydrocodone, and hydromorphone in urine as trimethylsilyl and oxime derivatives by gas chromatography-mass spectrometry.
Broussard LA; Presley LC; Pittman T; Clouette R; Wimbish GH
Clin Chem; 1997 Jun; 43(6 Pt 1):1029-32. PubMed ID: 9191557
[TBL] [Abstract][Full Text] [Related]
15. The detection of hydromorphone in urine specimens with high morphine concentrations.
McDonough PC; Levine B; Vorce S; Jufer RA; Fowler D
J Forensic Sci; 2008 May; 53(3):752-4. PubMed ID: 18471228
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
Bertholf RL; Johannsen LM; Reisfield GM
J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720
[TBL] [Abstract][Full Text] [Related]
17. Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites.
Wang P; Stone JA; Chen KH; Gross SF; Haller CA; Wu AH
J Anal Toxicol; 2006 Oct; 30(8):570-5. PubMed ID: 17132254
[TBL] [Abstract][Full Text] [Related]
18. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
[TBL] [Abstract][Full Text] [Related]
19. Observations on the urine metabolic profile of codeine in pain patients.
Yee DA; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of ELISA Immunoassay and LC-QTOF for Opiate Screening.
Kennedy D; Dani M
J Anal Toxicol; 2020 May; 44(4):410-413. PubMed ID: 31897469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]